Literature DB >> 20519468

Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.

Frédéric Bert1, James R Johnson, Bénédicte Ouattara, Véronique Leflon-Guibout, Brian Johnston, Estelle Marcon, Dominique Valla, Richard Moreau, Marie-Hélène Nicolas-Chanoine.   

Abstract

Among patients with cirrhosis, infections caused by Escherichia coli organisms that translocate from the gut are a frequent and severe complication. One hundred ten E. coli isolates from 110 cirrhotic patients with spontaneous bacterial peritonitis and/or spontaneous bacteremia were characterized for their phylogenetic group and virulence genotype (34 extraintestinal virulence factor genes). Genetic relatedness was investigated by enterobacterial repetitive intergenic consensus sequence type 2 (ERIC-2) PCR typing and multilocus sequence typing. Phylogenetic groups A, B1, B2, and D accounted for 24%, 4%, 48%, and 24% of the population, respectively. Overall, 68 distinct ERIC-2 profiles were encountered. Eleven clonal groups, represented by multiple isolates (2 to 11) from the same sequence type (ST) or sequence type complex, were identified. These clonal groups accounted for 54 (49%) isolates overall. Membership in one of these clonal groups was more frequent among B2 isolates than non-B2 isolates (67% versus 32%, P < 0.001). The most frequent sequence types were ST95 (n = 13) and ST73 (n = 8), followed by the ST14 and ST10 complexes (n = 7). ST131 and ST69 were represented by three isolates each. Clonal group-associated isolates exhibited a greater prevalence of 11 virulence genes, including pap elements, than the other isolates. However, no association between clonal groups and host factors, type of infection, or mortality was observed. In conclusion, E. coli isolates causing spontaneous bacterial peritonitis and bacteremia in cirrhotic patients are genetically diverse. However, approximately half of the isolates belong to familiar clonal groups and exhibit extensive virulence profiles that may be associated with greater invasive potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519468      PMCID: PMC2916625          DOI: 10.1128/JCM.00516-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora.

Authors:  M Ljungdahl; M Lundholm; M Katouli; I Rasmussen; L Engstrand; U Haglund
Journal:  Scand J Gastroenterol       Date:  2000-04       Impact factor: 2.423

Review 3.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

4.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 5.  Bacterial translocation (BT) in cirrhosis.

Authors:  Reiner Wiest; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes.

Authors:  Frédéric Bert; Manette Juvin; Zahia Ould-Hocine; Gervais Clarebout; Emmanuelle Keller; Nicole Lambert; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 7.  Spontaneous bacterial peritonitis.

Authors:  J Such; B A Runyon
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

8.  Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing.

Authors:  Sara Y Tartof; Owen D Solberg; Amee R Manges; Lee W Riley
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 9.  Bacterial translocation and its consequences in patients with cirrhosis.

Authors:  Carlos Guarner; Germán Soriano
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.566

10.  Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress.

Authors:  Christian Macutkiewicz; Gordon Carlson; Edwin Clark; Ulrich Dobrindt; Ian Roberts; Geoffrey Warhurst
Journal:  Microbes Infect       Date:  2008-01-12       Impact factor: 2.700

View more
  32 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.

Authors:  M C Wang; W H Lin; C C Tseng; A B Wu; C H Teng; J J Yan; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-08       Impact factor: 3.267

3.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

4.  Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Authors:  Sheila Adams-Sapper; Binh An Diep; Francoise Perdreau-Remington; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

5.  Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection.

Authors:  Bente Olesen; Flemming Scheutz; Rebecca L Andersen; Megan Menard; Nadia Boisen; Brian Johnston; Dennis S Hansen; Karen A Krogfelt; James P Nataro; James R Johnson
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

6.  Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.

Authors:  Emily A Gurnee; I Malick Ndao; James R Johnson; Brian D Johnston; Mark D Gonzalez; Carey-Ann D Burnham; Carla M Hall-Moore; Jessica E McGhee; Alexander Mellmann; Barbara B Warner; Phillip I Tarr
Journal:  J Infect Dis       Date:  2015-05-12       Impact factor: 5.226

7.  Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.

Authors:  Rebecca I Waltner-Toews; David L Paterson; Zubair A Qureshi; Hanna E Sidjabat; Jennifer M Adams-Haduch; Kathleen A Shutt; Mark Jones; Guo-Bao Tian; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

8.  Prevalence of avian-pathogenic Escherichia coli strain O1 genomic islands among extraintestinal and commensal E. coli isolates.

Authors:  Timothy J Johnson; Yvonne Wannemuehler; Subhashinie Kariyawasam; James R Johnson; Catherine M Logue; Lisa K Nolan
Journal:  J Bacteriol       Date:  2012-03-30       Impact factor: 3.490

9.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries.

Authors:  R Izdebski; A Baraniak; J Fiett; A Adler; M Kazma; J Salomon; C Lawrence; A Rossini; A Salvia; J Vidal Samso; J Fierro; M Paul; Y Lerman; S Malhotra-Kumar; C Lammens; H Goossens; W Hryniewicz; C Brun-Buisson; Y Carmeli; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.